期刊文献+

Livin基因siRNA重组表达载体的构建 被引量:1

Construction Livin-specific siRNA expression vector
下载PDF
导出
摘要 目的构建针对人抑凋亡基因Livin的小干扰RNA(siRNA)重组表达质粒载体。方法通过分子克隆技术,设计并合成具有基因特异性的3组寡核苷酸片段,克隆到pmU6质粒载体,并经菌落PCR鉴定及测序鉴定,Livin的siRNA序列成功克隆到重组表达质粒载体中。结果经菌落PCR鉴定及测序鉴定证实,人Livin的siRNA序列成功克隆到表达载体中,插入序列正确。结论成功构建了Livin siRNA质粒表达载体,为后续研究降低或沉默Livin基因表达后能否有效抑制膀胱癌细胞增殖和促进细胞凋亡奠定了基础。 Objective The study aims to design and construct 3eukaryotic expression vectors of short hairpin RNA(shRNA)against Livin gene. Methods Three groups of double strand oligonucleotide fragments were synthesized and cloned respectively into pmU6 vector with molecular cloning technique.It was confirmed by colony PCR digestion and analysis of DNA sequencing. Results Colony PCR digestion and analysis of DNA sequencing,encoding Livin was exactly the same as the reported sequence of encoding human Livin in GenBank.The recombinant plasmid was constructed. Conclusions The expression vector of Livin-specific siRNA were constructed successfully which lay the foundation for subsequent study.
出处 《现代泌尿生殖肿瘤杂志》 2014年第4期228-230,234,共4页 Journal of Contemporary Urologic and Reproductive Oncology
基金 2012深圳市科技计划项目(医疗卫生类)非资助项目第231号
关键词 LIVIN 表达载体 小干扰RNA Livin Expression vectors Small interfering RNA
  • 相关文献

参考文献7

  • 1夏忠胜,朱兆华,张立勇,刘仲敏,Bao-Ling Adam.MDR1 siRNA对结肠癌细胞多药耐药性的影响[J].中山大学学报(医学科学版),2007,28(3):268-273. 被引量:6
  • 2李显文,杨罗艳,王红珊,胡建波,钟惟德,谢克基,王良圣,魏鸿蔼.凋亡抑制蛋白Livin在膀胱移行细胞癌中的表达及临床意义[J].临床泌尿外科杂志,2006,21(3):216-218. 被引量:8
  • 3萨姆布鲁克,费里奇,曼尼阿蒂斯.分子克隆实验指南[M].第2版.北京:科学出版社,1999.
  • 4Ding ZY, Li ZG, Xing YZ, et al. The construction of siRNA plasmid targeting mouse HIF-la and in vitro study of its inhi- bition effect[J]. Neurosci Bu11,2010,25(3) : 122-130.
  • 5Langlet-Bertin B, Leborgne C, Scherman D, et al. Design and evaluation of histidine-rich amphipathic peptides for siR- NA delivery[J]. Pharm Res, 2010,27(7) : 1426-1436.
  • 6Breton G, Yassine-Diab B, Cohn L, et al. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only mod- estly improves proliferative responses to Gag by CD8(+) T ceils from HIV-l-infected individuals[J]. J Clin Immunol, 2009, 29 (5) :637-645.
  • 7Gazzaniga P, Gradilone A, Giuliani L, et al. Expression and prognostic significance of LIVIN, SURVIVIN and other ap- optosis-related genes in the progression of superficial bladder cancer[J]. Ann Oncol, 2003,14(1) : 85-90.

二级参考文献18

  • 1Ashhab Y, Alian A, Polliack A,et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern[J].FEBS Lett,2001,495(1-2) :56-60.
  • 2Hussein M R, Haemel A K, Wood G S. Apoptosis and melanoma: molecular mechanisms[J]. Pathol, 2003,199(3):275-288.
  • 3Kasof G M, Gomes B C. Livin, a novel inhibitor of apoptosis protein family member[J]. J Biol Chem, 2001,276(5):3238-3246.
  • 4Gazzaniga P, Gradilone A, Giuliani L, et al. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer[J]. Ann Oncol, 2003,14(1):85-90.
  • 5GERMANN U A.PASTAN I.GOTTESMAN M M.P-glycoproteins:mediators of multidrug resistance[J].Semin Cell Biol,1993,4(1):63-76.
  • 6CAPLEN N J,PARRISH S,IMANI F,et al.Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems[J].Proc Natl Acad Sci U S A,2001,98(17):9742-9747.
  • 7LIPARDI C,WEI Q,PATERSON B M.RNAi as random degradative PCR:siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs[J].Cell,2001,107(3):297-307.
  • 8VAN RENSBURG C E.JOONE G K.O'SULLIVAN J F.Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates[J].Oncol Rep,2000,7(1):193-195.
  • 9LI J,XU L Z,HE K L,et al.Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line[J].Breast Cancer Res,2001,3(4):253-263.
  • 10KOK J W,VELDMAN R J,KLAPPE K,et al.Differential expression of sphingolipids in MRP1 overexpressing HT29 cells[J].Int J Cancer,2000,87(2):172-178.

共引文献14

同被引文献13

  • 1王同杉,游思洪,葛红梅,刘平.SiRNA沉默livin基因表达促进胃癌细胞凋亡[J].世界华人消化杂志,2007,15(22):2377-2381. 被引量:5
  • 2Saif MW, Zalonis A, Syrigos K. The clinical significance of autoantibodies in gastrointestinal malignancies: an overview [J]. Expert Opin Biol Ther, 2007,7:493-507.
  • 3Ashhab Y, Alian A, Polliack A, et al. Two splicing variants of a new inhibitor of apoprosis gene with different biogical properties and tissued is tribution pattern [J]. FEBS Lett, 2001,495:56-60.
  • 4Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member [J]. J Biol Chem, 2001, 276: 3238-3246.
  • 5Vucie D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of Apoptosis that is preferentially expressed in human melanomas[J]. Curr Biol,2000,10 : 1359-1366.
  • 6Zhou, Y. H. , et al. , TLR4 ligand/H (2) O ( 2 ) enhances TGF-betal signaling to induce metastatic potential of non- invasive breast cancer cells by activating non-Smad path- ways[J]. PLoS One, 2013. 8: 1- 10. doi: 10. 1371/jour- nal. pone. 0065906.
  • 7Yang Q, Wang Y, Lu X, et al. MiR-125b regulates epithe- lial-mesenchymal transition via targeting Sema4C in paclita- xel-resistant breast cancer cells[J]. Oncotarget, 2015, 6: 3268-3279.
  • 8Schuhmacher C, Reim D, Novotny A. Neoadjuvant treatment for gastric cancer[J]. J Gastric Cancer, 2013, 13: 73-78.
  • 9Oh DY, Bang YJ. Adjuvant and neoadjuvant therapy for gastric cancer[J]. Curr Treat Options Oncol, 2013, 14: 311-320.
  • 10Wei S C, Fattet L, Yang J. The forces behind EMT and tumor metastasis [J]. Cell Cycle, 2015,8 : 1- 2.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部